Connect Biopharma Teams with Ickey Woods and the Jovante Woods Foundation to Expand Asthma Education Program Nationwide

Core Points - Connect Biopharma Holdings Limited collaborates with the Jovante Woods Foundation to enhance asthma education and awareness, particularly focusing on acute asthma attacks [1][3] - The partnership aims to expand educational programming across the U.S. and includes a video package sharing Jovante Woods' story to highlight the dangers of acute asthma [3][4] - The initiative is driven by the need for improved treatments for acute asthma exacerbations, with Connect Biopharma advancing its Phase 2 Seabreeze STAT studies [4][8] Company Overview - Connect Biopharma is a clinical-stage biopharmaceutical company focused on transforming care for asthma and COPD, headquartered in San Diego, California [8] - The company is developing rademikibart, a monoclonal antibody targeting IL-4Rα, aimed at treating acute exacerbations of asthma and COPD [7][8] - Connect Biopharma has an exclusive collaboration agreement for rademikibart with Simcere in China [8] Foundation Activities - The Jovante Woods Foundation, established by Ickey and Chandra Woods, aims to raise awareness about asthma and educate families on treatment management [2] - The Foundation has organized educational events and fundraisers in various states, including Ohio, California, and Nevada [2] - The collaboration with Connect Biopharma will enhance the Foundation's reach and frequency of educational programming [5]